Carmelo Rizzari

30PUBLICATIONS
172CO-AUTHORS
Rheumatology and arthritisHaematological tumoursGene and molecular therapyEpidemiological methodsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|Mar 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Nov 03, 2025
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.

André Baruchel, Karsten Nysom, Hyoung Jin Kang

|Aug 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.

Gudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky

Pageof 5

Frequent Collaborators

5 joint publications

Franco Locatelli

4 joint publications

Thais Murciano-Carillo

4 joint publications

Scott C Howard

4 joint publications

Petr Smisek